Illumina Inc.,ILMN2.68%increase; green up pointing triangle a leading maker of the machines that sequence genes, said Monday it will pay $7.1 billion in cash and stock for a developer of a long ...

The regulatory body first opened an investigation into Illumina's $7.1 billion acquisition of GRAIL in July 2021, expressing concern the deal would negatively impact competition and innovation in ...

Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing legal battles with antitrust enforcers in the U.S. and Europe.

Illumina Inc. was formally ordered to undo its $7 billion acquisition of cancer-test provider Grail Inc. as the European Union ramped up a legal fight over a deal the firms completed without its ...

Gene sequencing company Illumina Inc will pay $7.1 billion in cash and stock to buy cancer test startup Grail Inc, the Wall Street Journal reported on Monday, citing people familiar with the matter.

Illumina said Thursday it has won in the Federal Trade Commission's case challenging its $7.1 billion acquisition of cancer detection company GRAIL.

U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc , pledging to keep selling its DNA sequencing services to other firms, as it ...

Illumina Inc.’s was ordered to unwind its $7 billion acquisition of cancer startup Grail by the Federal Trade Commission, an uncommon move by antitrust regulators who said the deal raises ...

The Federal Trade Commission said it would seek to block Illumina’s planned $7.1 billion acquisition of a developer of a long-sought blood test that promises to detect cancer early.

U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc, pledging to keep selling its DNA sequencing services to other firms, as it seeks ...

U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc , pledging to keep selling its DNA sequencing services to other firms, as it ...